Baum C - Search Results

1

Physiological promoters reduce the genotoxic risk of integrating gene vectors.

Zychlinski D, Schambach A, Modlich U, Maetzig T, Meyer J, Grassman E, Mishra A, Baum C. Zychlinski D, et al. Among authors: baum c. Mol Ther. 2008 Apr;16(4):718-25. doi: 10.1038/mt.2008.5. Epub 2008 Mar 4. Mol Ther. 2008. PMID: 18334985 Free article.

2

Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.

Schambach A, Bohne J, Chandra S, Will E, Margison GP, Williams DA, Baum C. Schambach A, et al. Among authors: baum c. Mol Ther. 2006 Feb;13(2):391-400. doi: 10.1016/j.ymthe.2005.08.012. Epub 2005 Oct 12. Mol Ther. 2006. PMID: 16226060 Free article.

3

Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.

Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Baum C, et al. Hum Gene Ther. 2006 Mar;17(3):253-63. doi: 10.1089/hum.2006.17.253. Hum Gene Ther. 2006. PMID: 16544975 Review.

4

Retrovirus vectors: toward the plentivirus?

Baum C, Schambach A, Bohne J, Galla M. Baum C, et al. Mol Ther. 2006 Jun;13(6):1050-63. doi: 10.1016/j.ymthe.2006.03.007. Epub 2006 Apr 24. Mol Ther. 2006. PMID: 16632409 Free article. Review.

5

Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.

Will E, Bailey J, Schuesler T, Modlich U, Balcik B, Burzynski B, Witte D, Layh-Schmitt G, Rudolph C, Schlegelberger B, von Kalle C, Baum C, Sorrentino BP, Wagner LM, Kelly P, Reeves L, Williams DA. Will E, et al. Among authors: baum c. Mol Ther. 2007 Apr;15(4):782-91. doi: 10.1038/sj.mt.6300083. Epub 2007 Feb 13. Mol Ther. 2007. PMID: 17299409 Free article.

6

Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.

Schambach A, Galla M, Maetzig T, Loew R, Baum C. Schambach A, et al. Among authors: baum c. Mol Ther. 2007 Jun;15(6):1167-73. doi: 10.1038/sj.mt.6300152. Epub 2007 Apr 3. Mol Ther. 2007. PMID: 17406345 Free article.

7

Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.

Cornils K, Lange C, Schambach A, Brugman MH, Nowak R, Lioznov M, Baum C, Fehse B. Cornils K, et al. Among authors: baum c. Mol Ther. 2009 Jan;17(1):131-43. doi: 10.1038/mt.2008.238. Epub 2008 Nov 11. Mol Ther. 2009. PMID: 19002163 Free PMC article.

8

Clinical application of lentiviral vectors - concepts and practice.

Schambach A, Baum C. Schambach A, et al. Among authors: baum c. Curr Gene Ther. 2008 Dec;8(6):474-82. doi: 10.2174/156652308786848049. Curr Gene Ther. 2008. PMID: 19075630 Review.

9

Preventing and exploiting the oncogenic potential of integrating gene vectors.

Modlich U, Baum C. Modlich U, et al. Among authors: baum c. J Clin Invest. 2009 Apr;119(4):755-8. doi: 10.1172/jci38831. J Clin Invest. 2009. PMID: 19348042 Free PMC article.

10

Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH, Schambach A, Charrier S, Galy A, Thrasher AJ, Bueren J, Baum C. Modlich U, et al. Among authors: baum c. Mol Ther. 2009 Nov;17(11):1919-28. doi: 10.1038/mt.2009.179. Epub 2009 Aug 11. Mol Ther. 2009. PMID: 19672245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

854 results

Search Page

Filters